Search Results - "Sester LS"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.

    Authors: Sester LS Galeeva I de Castilhos J et al.

    Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3088-3093.

    Publication Type: Journal Article

    Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

    Save to List
  2. 2

    Rethinking Multiple Myeloma Treatment: The Biological and Clinical Insights Guiding Immune-Based Combinations.

    Authors: Gullà A Dhodapkar MV Einsele H et al.

    Source: Blood cancer discovery [Blood Cancer Discov] 2026 Mar 04; Vol. 7 (2), pp. 176-194.

    Publication Type: Journal Article; Review

    Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

    Save to List
  3. 3

    Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma.

    Authors: Grözinger M Schlanke M Gröne J et al.

    Source: Leukemia [Leukemia] 2026 Feb; Vol. 40 (2), pp. 339-347. Date of Electronic Publication: 2025 Dec 22.

    Publication Type: Journal Article

    Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

    Save to List
  4. 4

    Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin lightchain amyloidosis requiring dialysis prior to initial anticlonal therapy.

    Authors: Sester LS Milani P Theodorakakou F et al.

    Source: Haematologica [Haematologica] 2025 Dec 01; Vol. 110 (12), pp. 3042-3052. Date of Electronic Publication: 2025 Jun 19.

    Publication Type: Journal Article; Multicenter Study

    Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

    Save to List
  5. 5

    Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma.

    Authors: Kauer J Sester LS Kriegsmann K et al.

    Source: Hematological oncology [Hematol Oncol] 2023 Aug; Vol. 41 (3), pp. 453-462. Date of Electronic Publication: 2023 Jan 26.

    Publication Type: Journal Article

    Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  6. 6

    [Teclistamab for the treatment of multiple myeloma].

    Transliterated Title: Teclistamab zur Therapie beim multiplen Myelom.

    Authors: Sester LS Goldschmidt H Nitschmann S

    Source: Innere Medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2023 Feb; Vol. 64 (2), pp. 214-216. Date of Electronic Publication: 2022 Dec 07.

    Publication Type: Journal Article

    Journal Info: Publisher: Springer Medizin Country of Publication: Germany NLM ID: 9918384885306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2731-7099 (Electronic) Linking ISSN: 27317080 NLM ISO Abbreviation: Inn Med (Heidelb) Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  7. 7

    IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells.

    Authors: Kehl N Kilian M Michel J et al.

    Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

    Save to List

Search Tools: